Osaic Holdings
BMY icon

Osaic Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Osaic Holdings’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49M Buy
850,792
+23,539
+3% +$1.35M 0.06% 344
2026
Q1 		$50.2M Buy
827,253
+35,779
+5% +$2.09M 0.07% 278
2025
Q4 		$42.7M Sell
791,474
-53,982
-6% -$2.6M 0.06% 316
2025
Q3 		$38.8M Buy
845,456
+155,925
+23% +$7.28M 0.05% 372
2025
Q2 		$33.4M Buy
689,531
+205,325
+42% +$10.1M 0.06% 331
2025
Q1 		$29.5M Sell
484,206
-3,378
-0.7% -$197K 0.07% 301
2024
Q4 		$27M Buy
487,584
+48,050
+11% +$2.68M 0.06% 314
2024
Q3 		$22.7M Buy
439,534
+10,284
+2% +$482K 0.05% 367
2024
Q2 		$17.8M Sell
429,250
-41,692
-9% -$1.87M 0.04% 434
2024
Q1 		$25.5M Sell
470,942
-62,725
-12% -$3.2M 0.06% 333
2023
Q4 		$27.4M Sell
533,667
-183,760
-26% -$9.65M 0.05% 378
2023
Q3 		$41.7M Buy
717,427
+113,536
+19% +$6.96M 0.06% 296
2023
Q2 		$38.6M Sell
603,891
-34,378
-5% -$2.31M 0.07% 251
2023
Q1 		$44.3M Sell
638,269
-15,483
-2% -$1.09M 0.08% 222
2022
Q4 		$47.1M Buy
653,752
+46,099
+8% +$3.48M 0.1% 207
2022
Q3 		$43.2M Sell
607,653
-17,560
-3% -$1.27M 0.1% 193
2022
Q2 		$48.1M Buy
625,213
+37,426
+6% +$2.85M 0.11% 187
2022
Q1 		$40.3M Buy
587,787
+12,158
+2% +$816K 0.08% 251
2021
Q4 		$35.9M Sell
575,629
-11,685
-2% -$685K 0.07% 273
2021
Q3 		$34.8M Buy
587,314
+17,311
+3% +$1.14M 0.07% 263
2021
Q2 		$38.1M Sell
570,003
-17,629
-3% -$1.15M 0.08% 246
2021
Q1 		$37.1M Buy
587,632
+24,879
+4% +$1.55M 0.09% 227
2020
Q4 		$34.9M Sell
562,753
-52,495
-9% -$3.23M 0.09% 211
2020
Q3 		$37M Buy
615,248
+11,134
+2% +$670K 0.11% 180
2020
Q2 		$35.5M Sell
604,114
-134,822
-18% -$8.06M 0.12% 177
2020
Q1 		$33.3M Buy
+738,936
New +$45.2M 0.14% 157

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Osaic Holdings's BMY Position: Q2 2026 in Review

Osaic Holdings increased its Bristol-Myers Squibb (BMY) stake by 2.8% in Q2 2026, buying an estimated $1.35M and bringing the position to 850,792 shares worth $49M. The position accounts for 0.06% of the portfolio, ranked #344.

Osaic Holdings first reported a position in BMY in Q1 2020 and has held it in 26 quarters since. The position peaked at $50.2M in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Osaic Holdings held 850,792 shares of Bristol-Myers Squibb worth $49M as of Q2 2026.
  • Osaic Holdings bought 23,539 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.35M.
  • Bristol-Myers Squibb made up 0.06% of Osaic Holdings's portfolio in Q2 2026, its #344 holding.
  • Osaic Holdings first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Bristol-Myers Squibb position peaked at $50.2M in Q1 2026.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.